title: DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice.
abstract: Cholesterol and docosahexenoic acid (DHA) may affect degenerative processes in Alzheimer's Disease (AD) by influencing Abeta metabolism indirectly via the vasculature. We investigated whether DHA-enriched diets or cholesterol-containing Typical Western Diets (TWD) alter behavior and cognition, cerebral hemodynamics (relative cerebral blood volume (rCBV)) and Abeta deposition in 8- and 15-month-old APP(swe)/PS1(dE9) mice. In addition we investigated whether changes in rCBV precede changes in Abeta deposition or vice versa. Mice were fed regular rodent chow, a TWD-, or a DHA-containing diet. Behavior, learning and memory were investigated, and rCBV was measured using contrast-enhanced MRI. The Abeta load was visualized immunohistochemically. We demonstrate that DHA altered rCBV in 8-month-old APP/PS1 and wild type mice[AU1]. In 15-month-old APP/PS1 mice DHA supplementation improved spatial memory, decreased Abeta deposition and slightly increased rCBV, indicating that a DHA-enriched diet can diminish AD-like pathology. In contrast, TWD diets decreased rCBV in 15-month-old mice. The present data indicate that long-term dietary interventions change AD-like pathology in APP/PS1 mice. Additionally, effects of the tested diets on vascular parameters were observed before effects on Abeta load were noted. These data underline the importance of vascular factors in the APP/PS1 mouse model of AD pathology.
authors.affiliation: Radboud University Nijmegen Medical Center, Donders Institute for Brain, Cognition and Behaviour, (department: Anatomy and Cognitive Neuroscience) Geert Grooteplein noord 21, PO BOX 9101, 6500 HB, Nijmegen, The Netherlands.
authors.forename: C R
authors.initials: CR
authors.lastname: Hooijmans
authors.forename: C E E M
authors.initials: CE
authors.lastname: Van der Zee
authors.forename: P J
authors.initials: PJ
authors.lastname: Dederen
authors.forename: K M
authors.initials: KM
authors.lastname: Brouwer
authors.forename: Y D
authors.initials: YD
authors.lastname: Reijmer
authors.forename: T
authors.initials: T
authors.lastname: van Groen
authors.forename: L M
authors.initials: LM
authors.lastname: Broersen
authors.forename: D
authors.initials: D
authors.lastname: Lütjohann
authors.forename: A
authors.initials: A
authors.lastname: Heerschap
authors.forename: A J
authors.initials: AJ
authors.lastname: Kiliaan
mesh_terms: D000375:Aging; D000544:Alzheimer Disease / Q000473:pathology* / Q000503:physiopathology / Q000523:psychology; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000818:Animals; D001284:Atrophy; D001522:Behavior, Animal; D001810:Blood Volume; D001921:Brain / Q000098:blood supply* / Q000473:pathology; D001923:Brain Chemistry; D002791:Cholesterol, Dietary / Q000008:administration & dosage*; D003071:Cognition; D004032:Diet; D004195:Disease Models, Animal; D004281:Docosahexaenoic Acids / Q000008:administration & dosage*; D005227:Fatty Acids / Q000032:analysis; D008297:Male; D018782:Maze Learning; D008568:Memory; D051379:Mice; D008822:Mice, Transgenic
chemical_list: D016229:Amyloid beta-Peptides; D002791:Cholesterol, Dietary; D005227:Fatty Acids; D004281:Docosahexaenoic Acids